New Alzheimer’s Drug Awaits Approval, Spurs Hope
Making Progress In January, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the
Read More
Alzheimer’s
Trio of Bills Aim to Ease Burden on Families Battling Alzheimer’s
No One Left Behind By MARK MORRIS Imagine receiving a diagnosis for a serious illness and then having to figure
Read More